Skip to main content
Clinical Trials/NCT05109013
NCT05109013
Unknown
Not Applicable

Juvenile Essential Arterial Hypertension and Vascular Reactivity in Systemic and Cerebral Circulation

Josip Juraj Strossmayer University of Osijek1 site in 1 country50 target enrollmentSeptember 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Child, Only
Sponsor
Josip Juraj Strossmayer University of Osijek
Enrollment
50
Locations
1
Primary Endpoint
Systemic microvascular function in children
Last Updated
4 years ago

Overview

Brief Summary

The main goal of this study is to investigate the association of the juvenile essential arterial hypertension with systemic micro- and macrovascular reactivity and cerebral vascular function, and to examine the potential impact of elevated oxidative stress on this associations.

Registry
clinicaltrials.gov
Start Date
September 1, 2021
End Date
December 31, 2023
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ines Drenjancevic

Head of Department of Physiology and Immunology Faculty of Medicine Osijek

Josip Juraj Strossmayer University of Osijek

Eligibility Criteria

Inclusion Criteria

  • healthy normotensive children and children with essential arterial hypertension

Exclusion Criteria

  • secondary arterial hypertension
  • other systemic diseases with immunopathology
  • neurodegenerative diseasesat
  • children that use therapy which has a high impact on vascular or immunological function (immunotherapy, immunosuppressive therapy, sistemic corticosteroid therapy etc..).

Outcomes

Primary Outcomes

Systemic microvascular function in children

Time Frame: Day 1.

Skin microvascular reactivity assessed by Laser Doppler flowmetry (post-occlusive reactive hyperemia, iontophoresis of acetylcholine and sodium nitroprusside) - measured in perfusion units (PU)

Systemic macrovascular function in children

Time Frame: Day 1.

Vascular ultrasound measurement of brachial artery response to vascular occlusion (flow mediated dilation; FMD, %)

Cerabral vascular function in children

Time Frame: Day 1.

Cerebral blood flow velocities assessed by transcranial Doppler sonography (cm/s)

Secondary Outcomes

  • Endocan(Day 1.)
  • Oxidative stress - thiobarbituric acid reactive substances (TBARS)(Day 1.)

Study Sites (1)

Loading locations...

Similar Trials